HHS vs HMN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 16, 2026

HHS

52.4
AI Score
VS
HMN Wins

HMN

67.3
AI Score

Investment Advisor Scores

HHS

52score
Recommendation
HOLD

HMN

67score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric HHS HMN Winner
Revenue 75.25M 872.80M HMN
Net Income -5.63M 82.80M HMN
Net Margin -7.5% 9.5% HMN
ROE -36.7% 5.5% HMN
ROA -6.4% 0.5% HMN
Total Assets 88.06M 15.60B HMN
Cash 5.18M 46.20M HMN

Relative Price Performance (Last 90 Days)

HHS 1M: -5.3% · 3M: +81.2% HMN 1M: -6.9% · 3M: -12.6%

Current Technical Phase

HHS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.2 · Price: $4.33

HMN

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.8%), weak momentum, RSI 42

RSI (14): 41.8 · Price: $45.98

Fundamentals Snapshot

Metric HHS HMN
Market Cap — —
Forward P/E 4.1 8.6
Trailing P/E — 10.7
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.2% 0.4%
Operating Margin -0.1% 0.1%
EPS -0.77 4.28
Dividend Yield — 0.03%

Frequently Asked Questions

Based on our detailed analysis, HMN is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.